6251 - 6260 of 8587 Results
Title
Year
-
RESTRICTEDTitle: The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid FormationJournal Name: Journal of the American Chemical SocietyPublisher: American Chemical Society (ACS)Vol: 136Issue #: 10Start Page: 3859End Page: 3868Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/ja411577tCitation Count: 238
- Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons2021OPENTitle: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neuronsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 156Issue #:Start Page: 105409End Page: 105409Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105409Citation Count: 27
- Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease2021OPENTitle: Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13360Citation Count: 8
- Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain Tissue2020RESTRICTEDTitle: Validation of a Reversed Phase UPLC-MS/MS Method to Determine Dopamine Metabolites and Oxidation Intermediates in Neuronal Differentiated SH-SY5Y Cells and Brain TissueJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 11Issue #: 17Start Page: 2679End Page: 2687Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00336Citation Count: 13
-
OPENTitle: Imaging-based DBS programming help: Does it help?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 109Issue #:Start Page: 105362End Page: 105362Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105362Best OA location URL: https://doi.org/10.1016/j.parkreldis.2023.105362Citation Count: 1
- Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress2018OPENTitle: Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stressJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 144Issue #:Start Page: 19End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.10.013Citation Count: 52
-
OPENTitle: Dietary antioxidants associated with slower progression of parkinsonian signs in older adultsJournal Name: Nutritional NeurosciencePublisher: Informa UK LimitedVol: 25Issue #: 3Start Page: 550End Page: 557Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/1028415x.2020.1769411Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7680274Citation Count: 25
- Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsy2023OPENTitle: Low clinical sensitivity and unexpectedly high incidence for neuropathologically diagnosed progressive supranuclear palsyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 5Start Page: 438End Page: 451Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10117158Citation Count: 15
- The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohort2019OPENTitle: The Parkinson’s phenome—traits associated with Parkinson’s disease in a broadly phenotyped cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0077-5Best OA location URL: https://www.nature.com/articles/s41531-019-0077-5.pdfCitation Count: 38
- A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease2019OPENTitle: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 514Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7359409Citation Count: 94